Eiger BioPharmaceuticals Inc. is a clinical-stage biopharmaceutical company focusing on the development and commercialization of targeted therapies for rare diseases. With a diverse pipeline and a strong leadership team, the company is well-positioned to address the unmet medical needs of patients worldwide.
